Alsachim has developed a new Tyrosine Kinase Inhibitors stable labeled standards, you can now get access to these standards to boost your research. Tyrosine Kinase inhibitors have always been [...]
5 Fluoro-uracil toxicity has been proven and a pre-treatment assessment is now mandatory. Alsachim has developed the standards essential for the analysis. Uracil [13C,15N2] [...]
A new and unique revelation has been uncovered by Alsachim. For the first time ever, the one of a kind stable labeled standard of Thiotepa, [13C6] Thiotepa, is available. This represents a big [...]
Alsachim has obtained ISO 13485 certification for its in vitro diagnostic kits business, demonstrating the company's ability to meet regulatory requirements and its commitment to the quality of [...]
Shimadzu, one of the world leaders in analytical instrumentation, has joined forces with the France-based Alsachim company, an independent contract research and development organization. [...]
Search on news
News categories
News archives
![[13C6] Brigatinib, new Tyrosine Kinase Inhibitors available now](/modules/prestablog/views/img/grid-for-1-7/up-img/thumb_14.jpg?ea3f343ec86c05575f9403e6d4fd9c98)
31.05.2019
![[13C6] Thiotepa: A new era for the anticancer research!](/modules/prestablog/views/img/grid-for-1-7/up-img/thumb_12.jpg?ea3f343ec86c05575f9403e6d4fd9c98)
